ArticleFrontiers in public health2025
Trends in the disease burden of maternal sepsis and other maternal infections attributable to iron deficiency from 1990 to 2021 and its projection until 2050.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Global burden of maternal sepsis and other maternal infections from 1990 to 2021, with projections to 2050: risk factors and trends.Open medicine (Warsaw, Poland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Iron deficiency is a key risk factor for maternal sepsis and other maternal infections (MSMIs). This study aims to investigate the trends of MSMIs attributable to iron deficiency based on data from the Global Burden of Disease (GBD) 2021 database. Methods: Data on MSMIs attributable to iron deficiency were utilized. Epidemiological tendencies were assessed using the estimated annual percentage change (EAPC) for age-standardized rate in mortality (ASMR) and disability-adjusted life years (DALYs). The correlation between socio-demographic index (SDI) and age-standardized rates (ASRs) of deaths and DALYs in different GBD regions was evaluated using the Pearson correlation coefficient. Bayesian age-period-cohort models were applied to predict the burden of MSMIs attributable to iron deficiency by 2050. Results: From 1990 to 2021, the global mortality and DALYs of MSMIs attributable to iron deficiency declined, with an EAPC of -2.49 (95% confidence interval (CI): -2.91 to -2.06) and -2.51 (95% CI: -2.92 to -2.10), respectively. The decrease of ASMR was the most in the high-middle SDI regions, while for age-standardized DALY rate, the most decrease was in the low-middle SDI regions. In 2021, Somalia represented the greatest burdens on deaths and DALYs, with an ASMR of 2.98 per 100,000 persons (95% uncertainty interval (UI): 1.30-5.12) and an age-standardized DALY rate of 177.38 per 100,000 persons (95% UI: 76.95-299.71). East Asia had the most decreases in the burdens of deaths and DALYs. Moreover, Equatorial Guinea represented the largest decreases in ASMR and age-standardized DALY rate. In 1990 and 2021, the peaks of MSMIs-related deaths (1,124 cases and 724 cases) and DALYs (82,593 cases and 53,355 cases) were found in the 20-24 years age group. The ASMR and age-standardized DALY rate of MSMIs attributable to iron deficiency were negatively correlated with SDI. Projections indicated a continued decrease in the burden of MSMIs attributable to iron deficiency by 2050. Conclusions: Over the past 30 years, the global burden of MSMIs attributable to iron deficiency has been decreasing, which is predicted to continually decrease by 2050. Targeted strategies for improving management in MSMIs attributable to iron deficiency should focus on 20-24 years population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.